{
  "zip": "3053",
  "sector": "",
  "longBusinessSummary": "Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. The company's lead therapeutic product candidate is CYP-001, which has completed Phase I clinical trial for the treatment of graft versus host disease. It also develops products for the treatment of asthma, heart attack, diabetic wounds, coronary artery disease, acute respiratory distress syndrome, brain cancer, melanoma, sepsis, osteoarthritis, and critical limb ischemia, which are in a preclinical model. The company has a partnership with Monash University, University of Sydney, the Cooperative Research Centre for Cell Therapy Manufacturing, University of New South Wales, Critical Care Research Group, Massachusetts General Hospital, and the Royal College of Surgeons in Ireland to develop stem cell therapies. It also has a strategic partnership with Fujifilm Corporation of Japan for the development and research of Cymerus technology. The company was formerly known as Eco Quest Limited and changed its name to Cynata Therapeutics Limited in October 2013. Cynata Therapeutics Limited was founded in 2011 and is based in Carlton, Australia.",
  "city": "Carlton",
  "phone": "61 3 9824 5254",
  "state": "VIC",
  "country": "Australia",
  "companyOfficers": [],
  "website": "http://www.cynata.com",
  "maxAge": 1,
  "address1": "62 Lygon Street",
  "fax": "61 3 9822 7735",
  "industry": "",
  "address2": "Level 3",
  "previousClose": 0.48,
  "regularMarketOpen": 0.48,
  "twoHundredDayAverage": 0.571529,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.48,
  "navPrice": null,
  "averageDailyVolume10Day": 0,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.48,
  "fiftyDayAverage": 0.52272725,
  "trailingAnnualDividendRate": null,
  "open": 0.48,
  "averageVolume10days": 0,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.417773,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.48,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 4030,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 45283584,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 928,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.48,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 4030,
  "fiftyTwoWeekHigh": 0.76,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.35,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.48,
  "exchange": "PNK",
  "shortName": "CYNATA THERAPEUTICS LTD",
  "longName": "Cynata Therapeutics Limited",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "CYYNF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_38323454",
  "uuid": "28d817bf-baca-395d-bfae-1d70727abd71",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": -0.51901,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 95658600,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.12,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1593475200,
  "heldPercentInstitutions": 0.2387,
  "netIncomeToCommon": null,
  "trailingEps": -0.037,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 4,
  "heldPercentInsiders": 0.13949999,
  "nextFiscalYearEnd": 1656547200,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 88489528,
  "enterpriseValue": 56219520,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.48,
  "logo_url": "https://logo.clearbit.com/cynata.com"
}